GBS Inc Stock, NASDAQ:GBS
GBS, Inc. operates as a biosensor diagnostic technology company. It develops saliva glucose biosensor monitoring systems, a saliva-based glucose test for people living with diabetes. The firm's Biosensor platform is a small, printable organic strip designed to put the power of accurate, timely diagnosis in the hands of patients and their primary health practitioners. The company was founded in 1995 and is headquartered in New York, NY.